The approval was based on the AMPLIFY trial, which evaluated acalabrutinib alongside venetoclax in adults with previously untreated CLL without del(17p) or TP53 mutation.
The workflow encompasses patient datacollection and screening, univariate regression analysis for initial variable selection, systematic comparison of 91 machine learning models,selection and ...
Roche, in collaboration with KlinRisk, Inc, has received CE-mark for the first AI-based risk stratification tool for assessment of progressive decline in kidney function. This tool will be launched as ...
"CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Pipeline"DelveInsight's,“CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2025,” report provides comprehensive insights ...
Wendtner has served on advisory boards for AbbVie, Amgen, Astrazeneca, BeOne Medicines, BIONTech, Cllag-Janssen, F. Hoffmann-La Roche, Genentech, Gilead, GSK ...
Chronic lymphocytic leukemia (CLL) is the most common leukemia in adult patients living in the western hemisphere. The annual incidence of CLL is 4.2/100 000 people, with median (interquartile range ...
An interim analysis of progression-free survival in this trial showed that ibrutinib–venetoclax was superior to fludarabine–cyclophosphamide–rituximab (FCR) among patients with chronic lymphocytic ...
The Gazette offers audio versions of articles using Instaread. Some words may be mispronounced. Six new Iowa counties have been added to the list of places where chronic wasting disease -- a ...
This report focuses on multiple aspects of predictive policing in the UK, including the systems themselves, the policing outcomes or decisions they influence, and the impact on individuals, groups and ...
A risk stratification algorithm may be able to predict which patients with advanced chronic liver disease are at risk of developing hepatocellular carcinoma (HCC), according to a large-scale ...
David is comprehensively experienced in many facets of financial and legal research and publishing. As an Investopedia fact checker since 2020, he has validated over 1,100 articles on a wide range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results